Sequential Immunization of Two Doses of Inactivated COVID-19 Vaccine (Omicron) in Vaccinated Population Aged 18 Years and Above
Clinical trial NCT05382871 · UNKNOWN
Trial details
- NCT number
- NCT05382871
- Sponsor
- China National Biotec Group Company Limited
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-27
- Primary completion
- 2023-07-27
- Enrollment
- 1804
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.